title: Dietary supplements in the treatment of nucleoside reverse transcriptase inhibitor-related mitochondrial toxicity.
authors.forename: Nils
authors.initials: N
authors.lastname: Venhoff
authors.forename: Bernhard
authors.initials: B
authors.lastname: Setzer
authors.forename: Dirk
authors.initials: D
authors.lastname: Lebrecht
authors.forename: Ulrich A
authors.initials: UA
authors.lastname: Walker
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects*; D001205:Ascorbic Acid / Q000494:pharmacology*; D002331:Carnitine / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D004272:DNA, Mitochondrial / Q000187:drug effects; D019587:Dietary Supplements; D003576:Electron Transport Complex IV / Q000235:genetics; D006801:Humans; D019344:Lactic Acid / Q000096:biosynthesis; D050356:Lipid Metabolism; D008928:Mitochondria / Q000187:drug effects*; D009705:Nucleosides / Q000009:adverse effects; D012194:RNA-Directed DNA Polymerase / Q000009:adverse effects*; D012256:Riboflavin / Q000494:pharmacology*; D013831:Thiamine / Q000494:pharmacology*; D014407:Tumor Cells, Cultured; D016047:Zalcitabine / Q000009:adverse effects*
chemical_list: D019380:Anti-HIV Agents; D004272:DNA, Mitochondrial; D009705:Nucleosides; D019344:Lactic Acid; D016047:Zalcitabine; D003576:Electron Transport Complex IV; D012194:RNA-Directed DNA Polymerase; D001205:Ascorbic Acid; D002331:Carnitine; D012256:Riboflavin; D013831:Thiamine